Skip to main content
. 2009 Jan;11(1):96–101. doi: 10.1593/neo.81264

Figure 4.

Figure 4

HhAntag691, 10 µM, resensitizes MDCKII/Pgp cells and MDCKII/MRP1 cells to colchicine treatment. Cells were plated at a density of 2 x 104 cells per well in a 96-well plate and were allowed to attach before incubating in medium containing colchicine in the presence or absence of 10 µM HhAntag691 for 3 days. Cell viability was assessed with the XTT assay and was expressed as percentage of the control cells with no drug added. Mean ± SEM, n = 3.